KR890001701B1 - New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives - Google Patents

New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives Download PDF

Info

Publication number
KR890001701B1
KR890001701B1 KR1019860004682A KR860004682A KR890001701B1 KR 890001701 B1 KR890001701 B1 KR 890001701B1 KR 1019860004682 A KR1019860004682 A KR 1019860004682A KR 860004682 A KR860004682 A KR 860004682A KR 890001701 B1 KR890001701 B1 KR 890001701B1
Authority
KR
South Korea
Prior art keywords
benzothiazol
formula
disubstituted
derivatives
alkyl group
Prior art date
Application number
KR1019860004682A
Other languages
Korean (ko)
Other versions
KR880000416A (en
Inventor
정상현
조군호
김원섭
Original Assignee
주식회사 럭키
허신구
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 럭키, 허신구 filed Critical 주식회사 럭키
Priority to KR1019860004682A priority Critical patent/KR890001701B1/en
Publication of KR880000416A publication Critical patent/KR880000416A/en
Application granted granted Critical
Publication of KR890001701B1 publication Critical patent/KR890001701B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

A method of the production for the title compds. (I)[R1= halogen atom (Cl, Br, F) or methyl; R2=C1-4 of alkyl) comprises (a) dissolving 18.47g of 2-amino-4-chloro-benzothiazol in 20ml of dimethylformamide and adding to 16.83g of KOH, (b) adding 37.84g of dimethylsulfate to the mixture having KOH and heating at 153≰C for 8hr, (c) extracting the mixture with 50ml of ethylacetate, (d) neutralizing a saturated aqueous soln. of sodium bicarbonate.

Description

3,4-디치환-벤조티아졸-2-온 유도체의 새로운 제조방법New preparation of 3,4-disubstituted-benzothiazol-2-one derivatives

본 발명은 다음 구조식(I)의 3,4-디치환-벤조티아졸-2-온 유도체(이하 "벤조티아졸론 유도체"라고함)의 새로운 제조방법에 관한 것이다.The present invention relates to a new process for the preparation of 3,4-disubstituted-benzothiazol-2-one derivatives of the following formula (I) (hereinafter referred to as "benzothiazolone derivatives").

Figure kpo00001
Figure kpo00001

여기서 R1은 할로겐 원자(예를들면 Cl,Br,F)또는 메틸기이며, R2는 C1-C4의 알킬기이다. 벤조티아졸론 유도체는 벼의 도열병(피리클라리아 오리자에)및 부패병(헬민토스포리움 시그모이데움)을 방지하는데 특히 효과적이고 잎,뿌리 토양의 어느 하나에 의해서도 적용될 수 있는 특징을 갖는다. 또한 기존의 항균제보다 방제가 빠르고 지속성이 긴 매우 강한 약효를 가지며, 온혈동물(예를들면 생쥐, 쥐, 병아리) 및 어류 (예를들면 잉어, 북미산 작은 물고기)에 대해 극히 낮은 독성을 나타내고 생물체내에 유독성이 거의 남지 않는다. 이제까지 알려진 벤조티아졸론 유도체의 제조방법으로서 독일연방공화국 공개특허 제 2924712호는 하기 일반식(Ⅲ)의 4-치환-2-아미노 벤조티아졸을 디아조화하여 일반식(IV)의 4-치환-2-할로벤조티아졸을 만든후 저급알콜과 염기성 축합체 존재하에서 반응하여 일반식(V)의 4-치환-2-알콕시 벤조티아졸을 만든 다음 촉매를 이용하여 열전위시켜 일반식(I)의 벤조티아졸론 유도체를 합성한다.Wherein R 1 is a halogen atom (eg Cl, Br, F) or a methyl group, and R 2 is an alkyl group of C 1 -C 4 . Benzothiazolone derivatives are particularly effective in preventing rice blast (pyrichloria orizae) and rot (Helmintosporium sigmide) and have the characteristics that can be applied by either leaf or root soil. In addition, it has a very strong effect, which is faster to control and longer lasting than conventional antimicrobial agents, and has extremely low toxicity to warm-blooded animals (e.g. mice, mice, chicks) and fish (e.g. carp, small fishes of North America). There is little toxicity left. As a method for preparing a benzothiazolone derivative known so far, German Patent Application Publication No. 2924712 discloses diazotizing 4-substituted-2-amino benzothiazole of the following general formula (III) to 4-substituted general formula (IV)- 2-halobenzothiazole was prepared, followed by reaction in the presence of a lower alcohol and a basic condensate to form 4-substituted-2-alkoxy benzothiazole of general formula (V), followed by thermal dislocation with a catalyst to formula (I). A benzothiazolone derivative is synthesized.

Figure kpo00002
Figure kpo00002

R1,R2는 상기에서 정의한 바와같고 X는 Cl 또는 Br이다. 또한 일본공개 특허공보 제 82-6935호 및 82-6972호는 하기 일반식(VI)의 2-치환-N-알킬아닐린을 삼급염기 존재하에서 하기 일반식(VII)의 클로로카보닐 셀페닐클로로라이드와 반응하여 하기 일반식(VIII)의 셀페닐클로라이드 유도체를 만든후 이를 알루미늄 클로라이드나 진한 황산에서 폐환 반응시켜 일반식(I)의 벤조티아졸 유도체를 얻는다.R 1 , R 2 are as defined above and X is Cl or Br. In addition, Japanese Patent Application Laid-Open Nos. 82-6935 and 82-6972 disclose 2-substituted-N-alkylanilines of the following general formula (VI) in the presence of a tertiary base. And a phenylthiazole derivative of the following general formula (VIII) to form a phenylthiazole derivative of the general formula (I) by ring closing the reaction in aluminum chloride or concentrated sulfuric acid.

Figure kpo00003
Figure kpo00003

이들의 방법들은 다단계 반응으로서 반응시간이 장시간 소요될뿐 아니라 조작이 어려우며 수율이 70-80%로 낮아 공업적 규모에서 실시하기 어려운 단점이 있다.These methods are a multi-stage reaction, not only takes a long reaction time, but also is difficult to operate and the yield is low to 70-80%, making it difficult to carry out on an industrial scale.

본 발명자는 상기와 같은 문제점들을 해결하기 위하여 예의 연구하여 일반식(II)의 4-치환-2-아미노벤조티아졸 유도체를 알칼리 금속수산화물 존재하에서 알킬화제와 반응하여 1단계 반응으로 원하는 목적화합물(I)을 고순도(96% 이상), 고수율(90% 이상)로 얻을 수 있음을 알게되어 본 발명을 완성하게 되었다. 즉 본 발명은 일반식(II)의 4-치환-2-아미노벤조티아졸 유도체를 알칼리 금속수산화물 존재하에서 알킬화제와 반응시켜 일반식(IX ) 또는 일반식(X)의 4급염을 만든후 이를 가수분해시킴을 특징으로 하는 일반식(I)의 3,4-디치환-벤조티아졸-2-온 유도체의 제조방법이다.The present inventors earnestly studied to solve the above problems, and react the 4-substituted-2-aminobenzothiazole derivative of the general formula (II) with an alkylating agent in the presence of an alkali metal hydroxide in a one-step reaction. The present invention was completed to know that can be obtained in high purity (more than 96%), high yield (more than 90%). That is, the present invention reacts the 4-substituted-2-aminobenzothiazole derivative of formula (II) with an alkylating agent in the presence of an alkali metal hydroxide to form a quaternary salt of formula (IX) or formula (X), A method for producing a 3,4-disubstituted-benzothiazol-2-one derivative of formula (I) characterized by decomposition.

Figure kpo00004
Figure kpo00004

상기식에서 R1은 불소, 염소, 브롬 또는 메틸기이고, R2는 C1-C4의 알킬기이고 R3및 R4는 상이하거나 동일하게 수소, C1-C8의 알킬기이거나, C4-C12의 싸이클로알킬기, 또는 산소, 질소가 포함된 싸이클로알킬기이고 Y는 요오드, 브롬, 염소 또는 알킬화제이온이다. 이하 본 발명을 상세히 설명하면 다음과 같다. 본 발명의 출발물질인 일반식(II)의 화합물인 4-치환-2-아미노벤조티아졸 유도체는 다음의 방법에 의해 제조될 수 있다.(J. Heterocyclic Chem.17, 1325(1980))Wherein R 1 is a fluorine, chlorine, bromine or methyl group, R 2 is an alkyl group of C 1 -C 4 and R 3 and R 4 are differently or identically an alkyl group of hydrogen, C 1 -C 8 , or C 4 -C A cycloalkyl group of 12 or a cycloalkyl group containing oxygen, nitrogen and Y is iodine, bromine, chlorine or an alkylating ion. Hereinafter, the present invention will be described in detail. The 4-substituted-2-aminobenzothiazole derivative, which is a compound of formula (II), which is a starting material of the present invention, can be prepared by the following method. (J. Heterocyclic Chem. 17, 1325 (1980))

본 발명에 사용되는 알칼리금속 수산화물의 예로는 KOH, NaOH, K2CO3, NaHCO3, Na2CO3, Mg(OH)2, Ca(OH)2로서 사용량은 일반식(II) 화합물당 1몰 이상, 바람직하게는 3-8몰 이다. 또한 알킬화제의 예로는 디알킬 설페이트, 알킬할라이드, 트리알킬 포스페이트이며, 사용량은 일반식(II) 화합물당 1몰이상 바람직하게는 3-8몰이다. 본 반응은 용매 존재하 또는 부재하에서 수행될 수 있으며 용매로는 톨루엔, 벤젠, 크실렌, 클로로포름, 다이글라임 디메틸설폭사이드, 디메틸설페이트 디메틸포름아미드, 물등이다. 반응온도는 0℃ 이상이며 바람직하게는 실온 내지 용매의 환류온도에서 반응을 시킨다. 이하 실시예에 의해 상세히 설명하기로 한다.Examples of alkali metal hydroxides used in the present invention are KOH, NaOH, K 2 CO 3 , NaHCO 3 , Na 2 CO 3 , Mg (OH) 2 , Ca (OH) 2 , and the amount of the alkali metal hydroxide is 1 per compound of formula (II). More than one mole, preferably 3-8 moles. In addition, examples of the alkylating agent are dialkyl sulfate, alkyl halide and trialkyl phosphate, and the amount of the alkylating agent is 1 mole or more, preferably 3-8 moles per compound of formula (II). The reaction can be carried out in the presence or absence of a solvent and solvents include toluene, benzene, xylene, chloroform, diglyme dimethylsulfoxide, dimethylsulfate dimethylformamide, water and the like. Reaction temperature is 0 degreeC or more, Preferably it is made to react at room temperature to the reflux temperature of a solvent. It will be described in detail by the following examples.

[실시예 1]Example 1

4-클로로-3-메틸-벤조티아졸-2-온4-Chloro-3-methyl-benzothiazol-2-one

2-아미노-4-클로로-벤조티아졸 18.47g(0.1mol)을 20cc의 디메틸포름아미드에 녹이고, KOH 16.83g(0.3mol)을 소량의 물에 녹여 혼합한다. 이 혼합물에 디메틸설페이트 37.84g(0.3mol)을 넣고 가열하여 153℃에서 8시간 환류시켜 반응을 완결시킨다. 반응후 냉각하여 50cc의 에틸아세테이트로 추출하고 포화 중탄산나트륨수용액으로 세척후 용기용매를 감압증류하여 흰고체의 목적화합물 19.16g을 얻었다.18.47 g (0.1 mol) of 2-amino-4-chloro-benzothiazole is dissolved in 20 cc of dimethylformamide, and 16.83 g (0.3 mol) of KOH is dissolved in a small amount of water and mixed. 37.84 g (0.3 mol) of dimethyl sulfate was added to the mixture and heated to reflux at 153 ° C. for 8 hours to complete the reaction. After the reaction, the mixture was cooled, extracted with 50 cc of ethyl acetate, washed with saturated aqueous sodium bicarbonate solution, and the vessel solvent was distilled under reduced pressure to obtain 19.16 g of the target compound as a white solid.

수율 : 94.2%, 순도 : 98.0%Yield: 94.2%, purity: 98.0%

[실시예 2-14]Example 2-14

4-클로로-3-메틸-벤조티아졸-2-온4-Chloro-3-methyl-benzothiazol-2-one

다음 표 1 에 기재된 물질을 출발물질로 하여 실시예 1과 동일한 방법을 수행하여 표 1 의 결과를 얻었다.Next, the results of Table 1 were obtained in the same manner as in Example 1, using the materials listed in Table 1 as starting materials.

[표 1]TABLE 1

Figure kpo00005
Figure kpo00005

[실시예 15]Example 15

4-클로로-3-에틸-벤조티아졸-2-온4-Chloro-3-ethyl-benzothiazol-2-one

2-아미노-4-클로로벤조티아졸 18.47g(0.1mol)을 20cc의 다이글라임에 녹이고 K2CO341.46g(0.3mol) 및 물 1.8cc와 디에틸설페이트 46.25g(0.3mol)을 넣고 가열한다. 162℃에서 12시간 환류시킨후 냉각하여 50cc의 에틸아세테이트로 추출한다. 유기층을 포화중 탄산나트륨수용액으로 세척한후 감압증류하여 유기용매를 제거하면 목적화합물 19.88g을 얻는다.18.47 g (0.1 mol) of 2-amino-4-chlorobenzothiazole was dissolved in 20 cc of diglyme, and 41.46 g (0.3 mol) of K 2 CO 3, 1.8 cc of water and 46.25 g (0.3 mol) of diethyl sulfate were added thereto. Heat. After refluxing at 162 ° C. for 12 hours, the mixture was cooled and extracted with 50 cc of ethyl acetate. The organic layer was washed with saturated aqueous sodium carbonate solution and distilled under reduced pressure to remove the organic solvent to obtain 19.88 g of the target compound.

수율 : 91.1%, 순도 : 97.8%Yield: 91.1%, Purity: 97.8%

[실시예 16-31][Example 16-31]

4-클로로-3-에틸-벤조티아졸-2-온4-Chloro-3-ethyl-benzothiazol-2-one

다음 표 2 에 기재된 물질을 출발물질로 하여 실시예 15와 동일한 방법을 수행하여 표 2 의 결과를 얻었다.Next, the result of Table 2 was obtained by performing the same method as Example 15 using the material of Table 2 as a starting material.

[표 2]TABLE 2

Figure kpo00006
Figure kpo00006

[실시예 32]Example 32

4-브로모-3-메틸-벤조티아졸-2-온4-bromo-3-methyl-benzothiazol-2-one

2-아미노-4-브로모벤조티아졸 22.97g(0.1mol)을 20cc의 디메틸포름아미드(DMF)에 녹이고, K2CO341.46g(0.3mol) 및 물 1.8cc과 트리메틸소스페이트 28.02g(0.2mol)을 넣고 가열한 다음 153℃에서 10시간 환류시킨 후 냉각하여 에틸아세테이트 50cc로 추출하고 포화중탄산나트륨 수용액으로 세척한다. 그후 유기용매를 제거하여 22.91g의 목적 화합물을 얻는다.22.97 g (0.1 mol) of 2-amino-4-bromobenzothiazole was dissolved in 20 cc of dimethylformamide (DMF), 41.46 g (0.3 mol) of K 2 CO 3 and 1.8 cc of water and 28.02 g of trimethylsulfate ( 0.2 mol) was added thereto, heated to reflux at 153 ° C. for 10 hours, cooled, extracted with 50 cc of ethyl acetate, and washed with saturated aqueous sodium bicarbonate solution. The organic solvent is then removed to give 22.91 g of the desired compound.

수율 : 92.1%, 순도 : 98.4%Yield: 92.1%, Purity: 98.4%

[실시예 33-42]Example 33-42

4-브로모-3-메틸-벤조티아졸-2-온4-bromo-3-methyl-benzothiazol-2-one

다음 표 3 에 기재된 물질을 출발물질로 하여 실시예 32과 동일한 방법을 수행하여 표 1 의 결과를 얻었다.Next, the result of Table 1 was obtained in the same manner as in Example 32, using the material of Table 3 as a starting material.

[표 3]TABLE 3

Figure kpo00007
Figure kpo00007

[실시예 43]Example 43

3,4-디메틸-벤조티아졸-2-온3,4-dimethyl-benzothiazol-2-one

2-아미노-4-메틸-벤조티아졸 16.42g(0.1mol)을 녹이고 KOH 16,83(0.3mol), 1.8cc 물, 트리메틸포스페이트 28.02g(0.2mol)을 넣고 가열한다. 14시간 153℃에서 환류시킨후 냉각하여 에틸아세테이트 50cc로 추출하고 포화 중탄산나트륨수용액으로 세척한다. 그후 유기용매를 제거하여 16.84g을 목적화합물을 얻는다.Dissolve 16.42 g (0.1 mol) of 2-amino-4-methyl-benzothiazole, add KOH 16,83 (0.3 mol), 1.8 cc water, and 28.02 g (0.2 mol) of trimethylphosphate, and heat. The mixture was refluxed at 153 ° C. for 14 hours, cooled, extracted with 50 cc of ethyl acetate, and washed with saturated aqueous sodium bicarbonate solution. Thereafter, the organic solvent is removed to obtain 16.84 g of the target compound.

수율 : 91.1%, 순도 : 97.4%Yield: 91.1%, Purity: 97.4%

[실시예 44-53]Example 44-53

3,4-디메틸-벤조티아졸-2-온3,4-dimethyl-benzothiazol-2-one

다음 표 4 에 기재된 물질을 출발물질로 하여 실시예 43과 동일한 방법을 수행하여 표 1 의 결과를 얻었다.Next, the result of Table 1 was obtained in the same manner as in Example 43, using the material of Table 4 as a starting material.

[표 4]TABLE 4

Figure kpo00008
Figure kpo00008

[실시예 54]Example 54

4-플루오로-3-메틸-벤조티아졸-2-온4-fluoro-3-methyl-benzothiazol-2-one

2-아미노-4-플루오로-벤조티아놀 16.88g(0.1mol)을 20cc DMF에 녹이고 K2CO341.46g(0.3mol) 및 물 1.8cc과 디메틸설페이트 37.84g(0.3mol)을 넣고 실시예 1과 동일한 방법으로 행하여 17.60g의 목적화합물을 얻는다.16.88 g (0.1 mol) of 2-amino-4-fluoro-benzothianol was dissolved in 20 cc DMF, followed by 41.46 g (0.3 mol) of K 2 CO 3, 1.8 cc of water, and 37.84 g (0.3 mol) of dimethyl sulfate. 17.60 g of the target compound are obtained in the same manner as in (1).

[실시예 55-62]Example 55-62

4-플루오로-3-메틸-벤조티아졸-2-온4-fluoro-3-methyl-benzothiazol-2-one

다음 표 5 에 기재된 물질을 출발물질로 하여 실시예 1과 동일한 방법을 수행하여 표 1 의 결과를 얻었다.Next, the result of Table 1 was obtained by performing the same method as Example 1 using the material of Table 5 as a starting material.

[표 5]TABLE 5

Figure kpo00009
Figure kpo00009

Claims (3)

일반식(II)로 나타내어지는 4-치환-2-아미노벤조티아졸 유도체를, 알칼리금속 수산화물 존재하에서 알킬화제와 반응시켜 일반식(IX ) 또는 일반식(X)으로 나타내어지는 4급염을 만든후, 이를 가수분해 시킴으로써 얻어지는 것을 특징으로 하는 일반식(I)로 나타내어지는 3,4-디치환-벤조티아졸-2-온 유도체의 제조방법.The 4-substituted-2-aminobenzothiazole derivative represented by formula (II) is reacted with an alkylating agent in the presence of an alkali metal hydroxide to form a quaternary salt represented by formula (IX) or formula (X), A method for producing a 3,4-disubstituted-benzothiazol-2-one derivative represented by general formula (I), which is obtained by hydrolyzing this.
Figure kpo00010
Figure kpo00010
(상기식에서 R1은 불소, 염소, 브롬 또는 메틸기이고, R2는 C1-C4의 알킬기이고, R3및 R4는 상이하거나 동일한 수소, C1-C8의 알킬기이거나, C4-C12의 싸이클로 알킬기 또는 산소, 질소가 포함된 싸이클로 알킬기이며, Y는 요오드, 브롬, 염소 또는 알킬화제이온을 나타냄.)(Wherein R 1 is a fluorine, chlorine, bromine or methyl group, R 2 is an alkyl group of C 1 -C 4 , R 3 and R 4 are different or identical hydrogen, an alkyl group of C 1 -C 8 , or C 4- C 12 is an alkyl group or a cycloalkyl group containing oxygen and nitrogen, and Y represents iodine, bromine, chlorine or alkylating ion.)
제 1 항에 있어서, 알카리금속 수산화물이 KOH, NaOH, K2CO3, Na2CO3, NaHCO3, Mg(OH)2, Ca(OH)2임을 특징으로 하는 3,4-디치환-벤조티아졸-2-온 유도체의 제조방법.The 3,4-disubstituted-benzothiazol-2-one derivative according to claim 1, wherein the alkali metal hydroxide is KOH, NaOH, K2CO3, Na2CO3, NaHCO3, Mg (OH) 2, Ca (OH) 2. Manufacturing method. 제 1 항에 있어서, 알킬화제가 디메틸설페이트, 디에틸설페이트, 요오드메탄, 브로모메탄, 클로로메탄, 요오드에탄, 브로모에탄, 클로로에탄, 트리메틸포스페이트, 트리에틸 포스페이트 임을 특징으로 하는 3.4-디치환-벤조티아졸-2-온 유도체의 제조방법.3.4-Di-substituted according to claim 1, wherein the alkylating agent is dimethylsulfate, diethylsulfate, iodinemethane, bromomethane, chloromethane, iodineethane, bromoethane, chloroethane, trimethylphosphate, triethyl phosphate. Process for the preparation of benzothiazol-2-one derivatives.
KR1019860004682A 1986-06-12 1986-06-12 New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives KR890001701B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019860004682A KR890001701B1 (en) 1986-06-12 1986-06-12 New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019860004682A KR890001701B1 (en) 1986-06-12 1986-06-12 New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives

Publications (2)

Publication Number Publication Date
KR880000416A KR880000416A (en) 1988-03-25
KR890001701B1 true KR890001701B1 (en) 1989-05-18

Family

ID=19250457

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019860004682A KR890001701B1 (en) 1986-06-12 1986-06-12 New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives

Country Status (1)

Country Link
KR (1) KR890001701B1 (en)

Also Published As

Publication number Publication date
KR880000416A (en) 1988-03-25

Similar Documents

Publication Publication Date Title
US4826989A (en) Process for the preparation of luciferin compounds
USRE35389E (en) Process for the preparation of N-phosphonomethylglycine
KR890001701B1 (en) New process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives
ES2670677T3 (en) Manufacturing process of 5-chloromethyl-2,3-dicarboxylic anhydride
HU213315B (en) Process for producing arylacetic acids and their alkali metal salts
US4264770A (en) Process for preparing 1,4-bis-piperonylpiperazine and similar compounds
JPS5942359A (en) Preparation of sulfone
US5959118A (en) Process for the preparation of 5-hydroxymethylthiazoles
KR890001700B1 (en) Process for preparing 3,4-disubstituted-benzothiazole-2-on derivatives
US4118501A (en) Thiazolidine derivatives
KR100311949B1 (en) Process for the preparation of 1-[(cyclopent-3-en-1-yl)methyl]-5-ethyl-6-(3,5-dimethylbenzoyl)-2,4-pyrimidinedione
JP3899626B2 (en) Preparation of 2-mercaptothiazol
US3478095A (en) Preparation of phosphonamides
KR100466079B1 (en) A preparing process of phenoxyacetamide derivative
US2673879A (en) Substituted haloalkylamines
KR840002006B1 (en) Process for preparing 5-sulfamoyl-othanilic acids
KR910001998B1 (en) Process for the preparation of 2-(2-naphthyloxy) proponic acid derivation
KR900000553B1 (en) Method for making 3,4-disubstituted-benzo-thiazol-2-on derivaties
JPS6343382B2 (en)
JP4183781B2 (en) Method for producing S, S- (6-methylquinoxaline-2,3-diyl) dithiocarbonate
JPH09110756A (en) Production of bisphenol-type dimethylol compound
US4673749A (en) Process for producing an indoline
SU359821A1 (en)
KR870000865B1 (en) Prpeparation process of substituted benzoic acid derivatives
KR930004150B1 (en) Process for the preparation of 2,2'-methylene bis phenol derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19930330

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee